SNC-Lavalin Group Inc. (TSE:ATR – Free Report) – Research analysts at Desjardins issued their Q1 2025 earnings estimates for SNC-Lavalin Group in a research report issued to clients and investors on Friday, March 14th. Desjardins analyst B. Poirier anticipates that the company will earn $0.51 per share for the quarter. Desjardins also issued estimates for SNC-Lavalin Group’s Q2 2025 earnings at $0.59 EPS, Q3 2025 earnings at $0.82 EPS and Q4 2025 earnings at $0.99 EPS.
Separately, Stifel Canada raised shares of SNC-Lavalin Group to a “strong-buy” rating in a report on Tuesday, February 4th.
SNC-Lavalin Group Price Performance
SNC-Lavalin Group Company Profile
AptarGroup, Inc provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage.
Recommended Stories
- Five stocks we like better than SNC-Lavalin Group
- How to Invest in the FAANG Stocks
- How to Build the Ultimate Everything ETF Portfolio
- Stock Splits, Do They Really Impact Investors?
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- How to Invest in Insurance Companies: A Guide
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for SNC-Lavalin Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SNC-Lavalin Group and related companies with MarketBeat.com's FREE daily email newsletter.
